DBVT DBV Technologies S.A.

Nasdaq dbv-technologies.com


$ 14.14 $ -1.12 (-7.36 %)    

Thursday, 30-Oct-2025 15:59:49 EDT
QQQ $ 634.35 $ 0.00 (0 %)
DIA $ 475.79 $ 0.00 (0 %)
SPY $ 685.31 $ 0.00 (0 %)
TLT $ 90.29 $ 0.00 (0 %)
GLD $ 368.70 $ 0.00 (0 %)
$ 14.09
$ 14.65
$ 14.98 x 1,000
$ 15.55 x 1,000
-- - --
$ 2.20 - $ 18.00
49,874
na
2.38B
$ 0.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 07-29-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 04-11-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-07-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 07-31-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-01-2022 06-30-2022 10-Q
15 05-02-2022 03-31-2022 10-Q
16 03-09-2022 12-31-2021 10-K
17 10-26-2021 09-30-2021 10-Q
18 08-02-2021 06-30-2021 10-Q
19 05-05-2021 03-31-2021 10-Q
20 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-dbv-technologies-raises-price-target-to-20

HC Wainwright & Co. analyst Andrew S. Fein maintains DBV Technologies (NASDAQ:DBVT) with a Buy and raises the price targ...

 dbv-technologies-launches-150m-at-the-market-offering-program

DBV Technologies Establishes an At-The-Market (ATM) Program on NasdaqDBV Technologies (TRQX:DBVp) (the "Company"), a cl...

 dbv-technologies-q2-eps-031
DBV Technologies Q2 EPS $(0.31)
07/29/2025 21:10:01

 jmp-securities-reiterates-market-outperform-on-dbv-technologies-maintains-21-price-target

JMP Securities analyst Jonathan Wolleben reiterates DBV Technologies (NASDAQ:DBVT) with a Market Outperform and maintains $2...

 dbv-technologies-announces-it-has-screened-the-first-subject-in-comfort-toddlers-supplemental-safety-study-in-peanut-allergic-toddlers-1--3-years-old

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 –...

 goldman-sachs-reinstates-sell-on-dbv-technologies-announces-725-price-target

Goldman Sachs analyst Rajan Sharma reinstates DBV Technologies (NASDAQ:DBVT) with a Sell and announces $7.25 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION